These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22348322)

  • 1. International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis.
    Roscigno M; Cha EK; Rink M; Seitz C; Novara G; Chromecki TF; Fritsche HM; Matsumoto K; Walton TJ; Carballido J; Filippo Da Pozzo L; Bertini R; Ficarra V; Otto W; Karakiewicz PI; Pycha A; Fajkovic H; Naspro R; Scherr DS; Montorsi F; Shariat SF
    BJU Int; 2012 Sep; 110(5):674-81. PubMed ID: 22348322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification.
    Shariat SF; Zigeuner R; Rink M; Margulis V; Hansen J; Kikuchi E; Kassouf W; Raman JD; Remzi M; Koppie TM; Bensalah K; Guo CC; Mikami S; Sircar K; Ng CK; Haitel A; Kabbani W; Chun FK; Wood CG; Scherr DS; Karakiewicz PI; Langner C
    Eur Urol; 2012 Aug; 62(2):224-31. PubMed ID: 22285763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology Review.
    Seisen T; Mari A; Campi R; Peyronnet B; Bensalah K; Rioux-Leclercq N; Pfister C; Gobet F; De La Taille A; Allory Y; Xylinas E; Neuzillet Y; Radulescu C; Descotes JL; Saada-Sebag G; Irani J; Delpech-Debiais C; Bigot P; Eymerit C; Crouzet S; Mege-Lechevallier F; Ruffion A; Decaussin-Petrucci M; Droupy S; Roger P; Durand X; Camparo P; Cussenot O; Compérat E; Rouprêt M
    Eur Urol Focus; 2021 Sep; 7(5):1075-1083. PubMed ID: 33463527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pT3 subclassification of renal pelvic cancer considering the tumor location improves the patients' prognostic accuracy.
    Sano T; Kato M; Sassa N; Sadachi R; Hirakawa A; Kamihira O; Hirabayashi T; Nishikimi T; Katsuno S; Kimura T; Hattori R; Gotoh M; Tsuzuki T
    Virchows Arch; 2021 Jun; 478(6):1089-1097. PubMed ID: 33420835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripelvic/periureteral fat invasion is independently associated with worse prognosis in pT3 upper tract urothelial carcinoma.
    Park J; Park S; Song C; Hong JH; Kim CS; Ahn H
    World J Urol; 2014 Feb; 32(1):157-63. PubMed ID: 23568447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.
    Tanaka N; Kikuchi E; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakamura S; Oya M
    BJU Int; 2013 May; 111(6):857-64. PubMed ID: 22757942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclassification of pT3 upper tract urothelial carcinoma: a multicenter retrospective study.
    Yamada Y; Nakagawa T; Miyakawa J; Kawai T; Taguchi S; Tabata M; Kaneko T; Ishikawa A; Miyazaki H; Kondo Y; Matsumoto A; Naito A; Hikatsu M; Fujii Y; Akiyama Y; Yamada Y; Sato Y; Nomiya A; Yamada D; Murata T; Suzuki M; Enomoto Y; Nishimatsu H; Takeuchi T; Tanaka Y; Kume H
    World J Urol; 2023 Mar; 41(3):767-776. PubMed ID: 36739339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is pT3 urothelial carcinoma of the renal pelvis a homogeneous disease entity? Proposal for a new subcategory of the pT3 classification.
    Sassa N; Tsuzuki T; Fukatsu A; Majima T; Kimura T; Nishikimi T; Yoshino Y; Hattori R; Gotoh M
    Histopathology; 2012 Oct; 61(4):620-8. PubMed ID: 22730905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reassessment of prognostic heterogeneity of pT3 renal pelvic urothelial carcinoma: analysis in terms of proposed pT3 subclassification systems.
    Park J; Habuchi T; Arai Y; Ohyama C; Inoue T; Hatakeyama S; Jeon SS; Kwon GY; Kwak C; Moon KC; Kim CS; Ahn H
    J Urol; 2014 Oct; 192(4):1064-71. PubMed ID: 24735938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
    Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
    BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
    Fritsche HM; Novara G; Burger M; Gupta A; Matsumoto K; Kassouf W; Sircar K; Zattoni F; Walton T; Tritschler S; Baba S; Bastian PJ; Martínez-Salamanca JI; Seitz C; Otto W; Wieland WF; Karakiewicz PI; Ficarra V; Hartmann A; Shariat SF
    Urol Oncol; 2012 Sep; 30(5):666-72. PubMed ID: 20933445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort study.
    Suhara Y; Urabe F; Yoshihara K; Kurawaki S; Fukuokaya W; Iwatani K; Imai Y; Sakanaka K; Hisakane A; Kurauchi T; Kayano S; Onuma H; Mori K; Kimura S; Tashiro K; Tsuzuki S; Miki J; Sato S; Takahashi H; Kimura T;
    Int J Urol; 2024 Feb; 31(2):125-132. PubMed ID: 37828777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma.
    Nazzani S; Mazzone E; Preisser F; Tian Z; Mistretta FA; Shariat SF; Montanari E; Acquati P; Briganti A; Saad F; Carmignani L; Karakiewicz PI
    Eur J Surg Oncol; 2019 Jul; 45(7):1238-1245. PubMed ID: 30563773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
    Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy.
    Ouzzane A; Colin P; Xylinas E; Pignot G; Ariane MM; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Bruyère F; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M;
    Eur Urol; 2011 Dec; 60(6):1258-65. PubMed ID: 21665356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pronostic value of parenchyma renal invasion of pT3 upper tract urinary carcinoma].
    Bruzzi M; Le Goux C; Pignot G; Amsellem-Ouazana D; Vieillefond A; Patard JJ; Zerbib M
    Prog Urol; 2014 Jul; 24(9):556-62. PubMed ID: 24975790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.
    Wu CF; Pang ST; Chen CS; Chuang CK; Chen Y; Lin PY
    J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.